Samuel has expertise in domestic and cross-border corporate/M&A and capital markets transactions. Samuel’s M&A practice includes both public tender offers and private transactions for strategic and financial buyers and sellers. He also advises issuers and investment banks in IPOs, rights offerings, convertible bonds, PIPE transactions, block trades and other capital market transactions, and advises listed and private companies on corporate law and governance matters.

Matters in which Samuel acted as counsel include the representation of:

• Swiss Steel in the divestiture of its Eastern European entities (2023)
• Macquarie Asset Management in its USD 325m investment in Atlas Agro Holding AG (2023)
• SIX listed Autoneum in its rights offering (2023)
• Affidea in connection with its acquisitions of Brust-Zentrum Zurich and Plastic Surgery Group (2022/2023)
• Marché Restaurants in connection with its acquisition of Popeyes Restuarants (2022)
• NYSE and Mexican Stock Exchange listed FEMSA in the CHF 1.14 billion public takeover of SIX listed Valora Holding (2022)
• SVB Securities, Piper Sandler and LifeSci Capital as joint bookrunners/financial advisors in the public offering and private placement of Nasdaq listed VectivBio Holding AG (2022)
• International Chemical Investors Group (ICIG) on the sale of CordenPharma to European private equity firm Astorg (2022)
• SIX listed SFS Group on the acquisition of Hoffmann SE (2021)
• Coop in connection with the acquisition of Interkauf AG (operating the shopping center Perry Center, Oftringen) (2021)
• Transgrourmet in connection with the acquisition of GM Food, Spain operating cash & carry markets (2021)
• Coop in connection with its acquisition of Jumbo (2021)
• Swiss Steel in connection with the contested CHF 247m capital increase (2021)
• NEC Corporation in the CHF 2.05bn acquisition of Swiss Avaloq Group (2020)
• ASSA ABLOY on the acquisition of a controlling stake in agta record ag (2019)
• Worldline (Atos) in the CHF 2.75 billion acquisition of SIX Payment Services (2018)
• Landis+Gyr Group and its shareholders Toshiba and INCJ in the dual track exit process resulting in the CHF 2.3 billion IPO of Landis+Gyr Group on SIX, the largest Swiss IPO of the past 10 years and second largest IPO in Europe 2017
• Actelion in connection with the public tender offer by Johnson & Johnson to the shareholders of Actelion and in connection with the demerger of Idorsia from Actelion (2017)
• BioTelemetry, Inc. in connection with its competing public tender offer to the shareholders of LifeWatch AG (2017)